Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy

scientific article published on 23 April 2014

Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10549-014-2968-9
P698PubMed publication ID24756187

P50authorEric WinerQ16887072
Ines Vaz-LuisQ87608362
Rachel A FreedmanQ87938499
Nancy U LinQ89531596
Nancy KeatingQ91842955
Huichuan LiiQ125263909
P2093author name stringWilliam T Barry
P433issue2
P304page(s)491-501
P577publication date2014-04-23
P1433published inBreast Cancer Research and TreatmentQ326085
P1476titlePatterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy
P478volume145

Reverse relations

cites work (P2860)
Q39089103Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527
Q40583931Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
Q44446068Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change
Q58605565Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California
Q87938502Breast cancer-specific survival by age: Worse outcomes for the oldest patients
Q38670254Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.
Q31032887Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data
Q37258848Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes
Q90577057Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients
Q47575598Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy
Q94561483Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies
Q41457799Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients
Q28079170Specific Aspects of Breast Cancer Therapy of Elderly Women
Q36754437Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
Q92365181The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence
Q38594154Treatment of Breast Cancer in the Elderly
Q91045690Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016)
Q28079391Twenty years of anti-HER2 therapy-associated cardiotoxicity

Search more.